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background: Whether or not acute stent malapposition (ASM) may impact on long-term clinical follow-up of pts undergoing percutaneous 
coronary intervention (PCI) is still controversial.
Methods: ADAPT-DES was a prospective multicenter study of 8,582 pts undergoing PCI using drug-eluting stents. A pre-specified IVUS sub-study 
enrolled 2,072 pts including 2,446 culprit lesions with post-PCI grayscale IVUS. Pre-PCI virtual histology (VH) IVUS was available in 894 culprit 
lesions. Lesions with and without ASM were compared.
results: Overall, 12.6% (308) culprit lesions had ASM as assessed using post-PCI IVUS. The median [IQR] max malapposition area was 2.1 (1.4, 
3.4) mm2 and the total length of malapposition was 1.4 (0.7, 2.7) mm. ASM was located at the proximal stent edge in 19.5%, at the distal stent 
edge in 24.4%, and in the stent body in 61.7%. ASM was more prevalent in males, in pts with renal insufficiency, and in RCA lesion location. Pre VH-
IVUS showed more calcified thick-cap fibroatheromas (Ca-ThCFA) and more dense calcium (DC) in lesions with ASM. Lesions with ASM were treated 
with longer stents, and post grayscale-IVUS showed larger reference lumen and minimum lumen area (MLA) in lesions with ASM (Table). However, 
there was no relationship between ASM and MACE or stent thrombosis at 30-day and 2-year follow-up.
conclusion: Acute stent malapposition is seen in larger vessels and calcified lesions, but is not associated with adverse clinical events during 
short or long-term follow-up.
Malapposition No malapposition P-value
Patient level data N=299 pts N=1773 pts
Male 80.3% (240) 74.6% (1322) 0.03
Renal insufficiency 13.4% (40) 8.8% (156) 0.01
30-day follow-up
MACE (cardiac death, MI or TLR) 0.67% (2) 0.45% (8) 0.62
Stent thrombosis (definite/probable) 0.67% (2) 0.23% (4) 0.19
2-year follow-up
MACE (cardiac death, MI or TLR) 9.3% (57) 8.1% (140) 0.47
Stent thrombosis (definite/probable) 1.01% (3) 0.63% (11) 0.45
Myocardial infarction 4.1% (12) 3.1% (53) 0.34
Clinically driven target lesion revascularization 5.0% (15) 4.3% (76) 0.57
Pre VH-IVUS findings N=107 lesions N=787 lesions
Dense calcium volume, % 12.0±7.2 10.3±7.3 0.02
Calcified-ThCFA at MLA site 26.2% (28) 18.7% (147) 0.09
Post IVUS findings N=308 lesions N=2138 lesions
Stent length (mm) 30.1±19.1 27.8±17.1 0.045
Reference lumen area (mm2) 10.6±4.2 8.4±3.3 <0.0001
MLA (mm2) 6.5±2.4 6.2±2.3 0.015
Mean lumen area (mm3/mm) 8.1±2.6 7.7±2.6 0.015
Superficial calcium at reference 52.6% (162) 44.3% (95) 0.007
